﻿{"id":1537222,"date":"2020-09-30T00:04:24","date_gmt":"2020-09-29T21:04:24","guid":{"rendered":"http:\/\/www.erzurumflas.com\/torasik-kanserlerde-immuno-onkolojik-kombinasyon-tedavisi-etkili\/"},"modified":"2020-09-30T00:04:26","modified_gmt":"2020-09-29T21:04:26","slug":"torasik-kanserlerde-immuno-onkolojik-kombinasyon-tedavisi-etkili","status":"publish","type":"post","link":"https:\/\/www.erzhaber.com.tr\/?p=1537222","title":{"rendered":"Torasik kanserlerde, \u0130mm\u00fcno-Onkolojik Kombinasyon tedavisi etkili"},"content":{"rendered":"<p><img decoding=\"async\" src=\"http:\/\/www.erzurumflas.com\/wp-content\/uploads\/2020\/09\/torasik-kanserlerde-immuno-onkolojik-kombinasyon-tedavisi-etkili_e1afcf9.jpg\" width=\"600\">Kemoterapi e\u015fli\u011finde imm\u00fcno-onkolojik kombinasyon tedavisi kullan\u0131m\u0131n\u0131n, k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanseri hastalar\u0131n\u0131n sa\u011fl\u0131kla ili\u015fkili ya\u015fam kalitelerini s\u00fcrd\u00fcrmesine veya iyile\u015fmesine katk\u0131 sa\u011flad\u0131\u011f\u0131 ortaya konuldu.<\/p>\n<p>Avrupa T\u0131bbi Onkoloji Derne\u011fi 2020 Kongresi\u2019ne kat\u0131lan Dicle \u00dcniversitesi Hastanesi T\u0131p Fak\u00fcltesi T\u0131bbi Onkoloji Ana Bilim \u00d6\u011fretim \u00dcyesi Prof. Dr. Muhammet Ali Kaplan, k\u00fc\u00e7\u00fck h\u00fccreli d\u0131\u015f\u0131 akci\u011fer kanseri hastalar\u0131n\u0131n 1.basamak tedavilerine y\u00f6nelik yay\u0131nlanan yeni sonu\u00e7lar\u0131n da heyecan verici oldu\u011funu dile getirdi. Kaplan \u201cBir klinik \u00e7al\u0131\u015fma kapsam\u0131nda hastalar taraf\u0131ndan bildirilen sonu\u00e7 verilerine g\u00f6re, iki k\u00fcr kemoterapi ile \u0130mm\u00fcno-onkolojik kombinasyon tedavisi g\u00f6ren hastalar\u0131, ba\u015flang\u0131\u00e7 d\u00fczeyine k\u0131yasla sa\u011fl\u0131kla ili\u015fkili ya\u015fam kalitelerini s\u00fcrd\u00fcrd\u00fcklerini veya iyile\u015ftirdiklerini ortaya koydu. Ayr\u0131ca kemoterapi ile imm\u00fcno-onkolojik kombinasyon tedavisinin birlikte kullan\u0131m\u0131n\u0131n hastalarda sa\u011fl\u0131\u011f\u0131n bozulma s\u00fcresini geciktirerek, kemoterapiye k\u0131yasla sa\u011fl\u0131kla ili\u015fkili ya\u015fam kalitesinde bozulma riskini de azaltt\u0131\u011f\u0131n\u0131 g\u00f6rd\u00fck. Daha \u00f6nce yap\u0131lan klinik \u00e7al\u0131\u015fmalara katk\u0131 yapan bu sonu\u00e7lar, iki k\u00fcr kemoterapi e\u015fli\u011finde imm\u00fcno-onkolojik kombinasyon tedavisi kullan\u0131m\u0131n\u0131n sa\u011fkal\u0131m s\u00fcresini \u00f6nemli \u00f6l\u00e7\u00fcde ve g\u00fcvenilir bi\u00e7imde artt\u0131rd\u0131\u011f\u0131na dair elimizdeki bilgileri g\u00fc\u00e7lendiriyor\u201d dedi.<\/p>\n<p>Kaplan, \u201cBe\u015f y\u0131ll\u0131k sa\u011fkal\u0131m oran\u0131 y\u00fczde 10\u2019un alt\u0131nda seyreden k\u00f6t\u00fc huylu akci\u011fer zar\u0131 kanserinin pek \u00e7ok klinik tedaviye diren\u00e7 g\u00f6sterdi\u011fini biliyoruz. Bu nedenle kongrede bu agresif kanser t\u00fcr\u00fcn\u00fcn tedavisine y\u00f6nelik payla\u015f\u0131lan yeni sonu\u00e7lar t\u0131p camias\u0131 a\u00e7\u0131s\u0131ndan heyecan verici bir ilk niteli\u011findeydi. K\u00f6t\u00fc huylu akci\u011fer zar\u0131 kanserinin t\u00fcm tiplerinde birinci basamak tedavi olarak uygulanan ikili bir imm\u00fcnoterapi kombinasyonunun kemoterapiye k\u0131yasla \u00fcst\u00fcn, kal\u0131c\u0131 genel sa\u011fkal\u0131m yarar\u0131 sa\u011flad\u0131\u011f\u0131n\u0131 g\u00f6rd\u00fck. \u0130mm\u00fcnoterapi kombinasyonu ile tedavi g\u00f6ren hastalar\u0131n\u0131n y\u00fczde 41\u2019inin iki y\u0131l sonunda hayatta oldu\u011fu g\u00f6rd\u00fck; bu oran kemoterapi tedavisi alan hastalarda ne yaz\u0131k ki y\u00fczde 27 ile s\u0131n\u0131rl\u0131 kald\u0131. Bu \u015fekilde imm\u00fcno-onkolojik kombinasyon tedavisinin torasik kanserlerde sa\u011fkal\u0131m beklentilerini de\u011fi\u015ftirme potansiyelini daha net bi\u00e7imde g\u00f6rebildik\u201d dedi.<\/p>\n<p>\u0130mm\u00fcno-onkoloji, \u00fczerinde \u00e7ok b\u00fcy\u00fck Ar-Ge ara\u015ft\u0131rmalar\u0131 yap\u0131lan kansere kar\u015f\u0131 geli\u015ftirilen yeni bir tedavi y\u00f6ntemidir. Kelime anlam\u0131 olarak, \u201cimm\u00fcno\u201d ba\u011f\u0131\u015f\u0131kl\u0131k sistemini, \u201conkoloji\u201d ise kanseri temsil etmektedir. Geleneksel tedavi y\u00f6ntemlerinde s\u00fcre\u00e7, do\u011frudan kanserli b\u00f6lge \u00fczerine odaklanmaktad\u0131r. \u0130mm\u00fcno-onkolojide ise tedavi, v\u00fccudun do\u011fal savunma sistemi olan ba\u011f\u0131\u015f\u0131kl\u0131k sisteminin kanserle m\u00fccadele etmesi prensibi \u00fczerine kuruludur. Fark\u0131ndal\u0131\u011f\u0131 artm\u0131\u015f ba\u011f\u0131\u015f\u0131kl\u0131k sistemi, kanser h\u00fccrelerinin yok edilmesinde daha etkili bir rol oynayarak iyile\u015fme s\u00fcrecini destekler. Ger\u00e7ekle\u015ftirilen klinik ara\u015ft\u0131rmalar\u0131n sonu\u00e7lar\u0131na g\u00f6re, kanser tedavisinde imm\u00fcno-onkolojik tedaviler kullan\u0131ld\u0131\u011f\u0131nda uzun d\u00f6nem sa\u011fkal\u0131m oranlar\u0131 artmaktad\u0131r. Bununla birlikte bu tedavilerin yan etkileri de di\u011fer kanser tedavilerine g\u00f6re daha y\u00f6netilebilir oldu\u011fundan hastalar\u0131n tedavi s\u00fcrecindeki ya\u015fam kalitesi de artmaktad\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>D\u0130CLE \u00dcN\u0130VERS\u0130TES\u0130 HASTANES\u0130 TIP FAK\u00dcLTES\u0130 TIBB\u0130 ONKOLOJ\u0130 ANA B\u0130L\u0130M \u00d6\u011eRET\u0130M \u00dcYES\u0130 PROF. DR. MUHAMMET AL\u0130 KAPLAN<\/p>\n","protected":false},"author":1,"featured_media":1537223,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,20],"tags":[72331,14818,84923,118124,17326,118123],"class_list":["post-1537222","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","category-turkiye","tag-immuno-onkolojik","tag-etkili","tag-kanserlerde","tag-kombinasyon","tag-tedavisi","tag-torasik"],"_links":{"self":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1537222","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1537222"}],"version-history":[{"count":0,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1537222\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/media\/1537223"}],"wp:attachment":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1537222"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1537222"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1537222"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}